[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-344821-105":59,"doc-detail-344821-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","col8a1-promotes-prostate-cancer-progression-via-modulating-tumor-immune-infiltration-and-activating-the-fakpi3kakt-pathway-through-adamts2-regulation","COL8A1 promotes prostate cancer progression via modulating tumor immune infiltration and activating the FAK/PI3K/AKT pathway through ADAMTS2 regulation","","Collagen type VIII alpha 1 chain (COL8A1) is implicated in tumor progression across cancers, yet its expression patterns and mechanisms in prostate cancer (PCa) remain insufficiently defined. This study integrates analyses of public datasets and clinical samples with cellular and in vivo functional assays to evaluate COL8A1 expression, tumor behaviors, protein interactions, and pathway activation. Results show COL8A1 upregulation correlates with advanced features, poor progression-free survival, increased proliferation, invasion, migration, immune infiltration, and accelerated tumor growth through the ADAMTS2-FAK/PI3K/AKT axis.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/col8a1-promotes-prostate-cancer-progression-via-modulating-tumor-immune-infiltration-and-activating-the-fakpi3kakt-pathway-through-adamts2-regulation/344821/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/col8a1-promotes-prostate-cancer-progression-via-modulating-tumor-immune-infiltration-and-activating-the-fakpi3kakt-pathway-through-adamts2-regulation/344821.png","ImageObject",300,407,{"name":92,"@type":93},"Lucas Martin","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"How was COL8A1 expression evaluated in prostate cancer?","Question",{"text":112,"@type":113},"COL8A1 levels were assessed using public datasets and clinical samples, including TCGA RNA-seq and a GEO dataset. Associations with clinicopathological features and prognosis were also analyzed.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What functional effects does COL8A1 have on prostate cancer cells?",{"text":117,"@type":113},"Functional assays indicate that COL8A1 promotes proliferation, invasion, and migration while inhibiting apoptosis. Tumor aggressiveness is enhanced in related experiments.",{"name":119,"@type":110,"acceptedAnswer":120},"What mechanism connects COL8A1 to signaling pathway activation?",{"text":121,"@type":113},"COL8A1 interacts with ADAMTS2, and altering this axis changes ADAMTS2 protein expression. This interaction stimulates the FAK/PI3K/AKT signaling pathway, and ADAMTS2 suppression partially reverses COL8A1 oncogenic effects.",{"name":123,"@type":110,"acceptedAnswer":124},"Does COL8A1 influence the tumor immune microenvironment and in vivo growth?",{"text":125,"@type":113},"COL8A1 expression is positively linked to immune cell infiltration in the tumor microenvironment. In vivo xenograft experiments confirm that COL8A1 knockdown suppresses tumor growth.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},344821,1790177277,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":36,"preview_page_count":19,"preview_urls":149},8796095360427,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nCOL8A1 promotes prostate cancer progression via modulating tumor immune infiltration and activating the FAK/PI3K/AKT pathway through ADAMTS2 regulation  \nJinrun Wang1,2, Jinzhuo Ning1,2, LizheXu1,2 & Fan Cheng1􀀍  \nCollagen type VIII alpha 1 chain (COL8A1) is a part of the collagen family and has been involved in tumor progression in numerous cancers. Nevertheless, its expression pattern, functional  \nrole, and underlying mechanisms in prostate cancer (PCa) remain largely unexplored. COL8A1 expression was analyzed using public datasets and clinical samples. Functional roles of COL8A1 in PCa cells were assessed via CCK-8, Transwell, wound healing, and flow cytometry assays. Protein interactions were assessed by co-immunoprecipitation and pull-down assays. The underlying mechanism was explored using Western blot (WB), bioinformatics analysis, and in vivo xenograft models. COL8A1 was significantly increased in PCa tissues and cell lines, and its expression related to advanced clinicopathological features and poor progression-free survival. Functional studies showed that COL8A1 promotes cell proliferation, invasion, and migration while inhibiting apoptosis. Mechanistically, COL8A1 interacts with ADAMTS2, and its modulation affects ADAMTS2 protein expression. This interaction results in stimulation of the FAK/PI3K/AKT pathway. ADAMTS2 suppression partially reversed the oncogenic effects of COL8A1 overexpression. Moreover, COL8A1 expression was positively linked to immune cell infiltration in the tumor microenvironment. In vivo experiments confirmed that COL8A1 knockdown suppresses tumor growth. Our findings identify COL8A1 as an innovative oncogenic driver in PCa that promotes tumor progression via modulation of the ADAMTS2-FAK/PI3K/AKT axis and immune infiltration. COL8A1 may be a potential prognostic biomarker and therapeutic target for PCa.  \nKeywords COL8A1, ADAMTS2, PCa, FAK/PI3K/AKT signaling pathway, Immune infiltration  \nPCa is a predominant malignancy in men worldwide, with its occurrence continuously growing, particularly in developed countries1. Even though early-stage PCa can often be effectively managed with surgery or radiotherapy, a significant percentage of individuals are diagnosed at advanced or metastatic stages, which greatly complicates therapeutic management2. The progression of PCa is closely associated with multiple molecular mechanisms, including aberrant activation of signaling pathways, remodeling of the tumor immune microenvironment, and enhanced invasive and metastatic capabilities of cancer cells3. Therefore, a deeper comprehension of the key molecular events driving PCa pathogenesis and progression, along with the determination of novel biomarkers and potential therapeutic targets, is of crucial importance for enhancing patient outcomes.  \nCOL8A1 is a collagen family protein that is primarily found in vascular endothelial cells and some mesenchymal cells4. It has been implicated in extracellular matrix (ECM) remodeling, angiogenesis, and tissue fibrosis5. Emerging evidence illustrates that COL8A1 is aberrantly expressed in numerous types of malignancy, such as nasopharyngeal, hepatic, and esophageal cancers, where it has been related to tumor invasion, metastasis, and poor clinical outcomes6–8. Nonetheless, the expression profile and function of COL8A1 in PCa are still largely unexplored. Investigating the biological functions and regulatory mechanisms of COL8A1 in PCa may provide novel insights into its role within the tumor microenvironment and offer potential therapeutic targets for the treatment of this malignancy.  \n1Department of Urology, Renmin Hospital of Wuhan University. Wuhan, Wuhan 430060, Hubei Province, PR China.  \n2Jinrun Wang, Jinzhuo Ning and LizheXu contributed equally to this work. 􀀍 email: [urology1969@aliyun.com](urology1969@aliyun.com)  \n[www. nature.com/scientificreports/](www. nature.com/scientificre","cbCaiuWOSasDqIrk","https://ap.wps.com/l/cbCaiuWOSasDqIrk","pdf",4006527,16,"English","# Materials and methods\n## Database\n## Bioinformatics","[{\"question\":\"How was COL8A1 expression evaluated in prostate cancer?\",\"answer\":\"COL8A1 levels were assessed using public datasets and clinical samples, including TCGA RNA-seq and a GEO dataset. Associations with clinicopathological features and prognosis were also analyzed.\"},{\"question\":\"What functional effects does COL8A1 have on prostate cancer cells?\",\"answer\":\"Functional assays indicate that COL8A1 promotes proliferation, invasion, and migration while inhibiting apoptosis. Tumor aggressiveness is enhanced in related experiments.\"},{\"question\":\"What mechanism connects COL8A1 to signaling pathway activation?\",\"answer\":\"COL8A1 interacts with ADAMTS2, and altering this axis changes ADAMTS2 protein expression. This interaction stimulates the FAK/PI3K/AKT signaling pathway, and ADAMTS2 suppression partially reverses COL8A1 oncogenic effects.\"},{\"question\":\"Does COL8A1 influence the tumor immune microenvironment and in vivo growth?\",\"answer\":\"COL8A1 expression is positively linked to immune cell infiltration in the tumor microenvironment. In vivo xenograft experiments confirm that COL8A1 knockdown suppresses tumor growth.\"}]","COL8A1 promotes prostate cancer progression via modulating tumor immune infiltration and activating the FAK/PI3K/AKT pathway through ADAMTS2 regulation | PDF",1790055363,[150,154,158,162],{"page_no":8,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/25ccde22ef4578b11d49a28e060daa2d.webp",983,1291,{"page_no":14,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/73c71dd10dd4e35a681804a688162927.webp",982,1290,{"page_no":81,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/51ec7d7118ff3ce221584f9ad4bac142.webp",981,1289,{"page_no":19,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8958b65687dba57324d296b7e74984be.webp",980,1287]